Charles R. Parker has joined Yetter Coleman, a Houston litigation boutique, as partner effective immediately.
More Stories
Tom Melsheimer is Superman
He’s brash, bold and paid nearly $1,000 an hour. But he will always be known for the Cuban motion.
Does The SEC Need An Office in Houston? Absolutely, Say Most Securities Lawyers
Houston is the largest city in the U.S. that does not have a SEC presence, despite being the home of some of the biggest financial frauds of the past decade, including Enron and Stanford Investments.
Texas Supreme Court Tackles Major Land Condemnation Dispute
Case is being closely watched by utilities, pipeline companies and property rights advocates.
Baker Botts, McKool Smith & Lidji Dorey Lead Dr Pepper and Dublin Bottler Settlement
The 1970s Dr Pepper commercial was catchy: “I’m a Pepper, he’s a Pepper, she’s a Pepper, wouldn’t you like to be a Pepper, too?”
Baker Botts, McKool Smith & Lidji Dorey Lead Dr Pepper and Dublin Bottler Settlement
The 1970s Dr Pepper commercial was catchy: “I’m a Pepper, he’s a Pepper, she’s a Pepper, wouldn’t you like to be a Pepper, too?”
Long-time IP Lawyer Robert Turner Joins McDole, Kennedy & Williams
Robert Turner, who has practiced intellectual property law for 45 years, has left Jones Day’s Dallas office.
Long-time IP Lawyer Robert Turner Joins McDole, Kennedy & Williams
Robert Turner, who has practiced intellectual property law for 45 years, has left Jones Day’s Dallas office.
Texas AG and Johnson & Johnson Battle in Opening Statements
In opening statements today in the state’s $1 billion false drug marketing case against Johnson & Johnson, a lawyer for the company said he will present “real world” evidence that the antipsychotic Risperdal was widely used by medical professionals on adults and children because it works better than competing products.
Texas AG and Johnson & Johnson Battle in Opening Statements
In opening statements today in the state’s $1 billion false drug marketing case against Johnson & Johnson, a lawyer for the company said he will present “real world” evidence that the antipsychotic Risperdal was widely used by medical professionals on adults and children because it works better than competing products.